Clifton GG - Search Results

1

Monoexponential analysis of plasma disappearance of 99mTc-DTPA and 131I-iodohippurate: a reliable method for measuring changes of renal function.

Clifton GG, Anderson C, McMahon G, Vargas R, Wallin JD. Clifton GG, et al. J Clin Pharmacol. 1989 May;29(5):466-71. doi: 10.1002/j.1552-4604.1989.tb03364.x. J Clin Pharmacol. 1989. PMID: 2661604

2

The effects of enoximone on renal function in patients with congestive heart failure.

Clifton G, McMahon G, Ryan J, Vargas R, Bekele T, Wallin D. Clifton G, et al. Clin Pharmacol Ther. 1989 Jan;45(1):85-91. doi: 10.1038/clpt.1989.13. Clin Pharmacol Ther. 1989. PMID: 2521320

3

Changes of plasma renin activity and atrial natriuretic factor during intravenous nicardipine treatment of severe hypertension.

Clifton GG, Cook ME, MacCarthy P, Bienvenu G, Walsh M, Turlapaty P, Wallin JD. Clifton GG, et al. Int J Clin Pharmacol Ther Toxicol. 1989 Dec;27(12):578-82. Int J Clin Pharmacol Ther Toxicol. 1989. PMID: 2533181

4

Effects of dilevalol on renal function.

Clifton GG, Cook ME, Wallin JD. Clifton GG, et al. Am J Cardiol. 1989 Jun 5;63(19):75I-78I. doi: 10.1016/0002-9149(89)90134-3. Am J Cardiol. 1989. PMID: 2729128

5

The renal function and blood pressure effects of dilevalol in the normotensive and hypertensive elderly.

Clifton GG, Cook ME, Poland M, Wallin JD. Clifton GG, et al. J Clin Pharmacol. 1989 Jul;29(7):603-8. doi: 10.1002/j.1552-4604.1989.tb03388.x. J Clin Pharmacol. 1989. PMID: 2760254 Clinical Trial.

6

Renal function effects of dilevalol, a nonselective beta-adrenergic blocking drug with beta-2 agonist activity.

Cook ME, Wallin JD, Clifton GG, Poland M. Cook ME, et al. Among authors: clifton gg. Clin Pharmacol Ther. 1988 Apr;43(4):393-9. doi: 10.1038/clpt.1988.49. Clin Pharmacol Ther. 1988. PMID: 3356083 Clinical Trial.

7

Intravenous nicardipine: an effective new agent for the treatment of severe hypertension.

Clifton GG, Wallin JD. Clifton GG, et al. Angiology. 1990 Nov;41(11 Pt 2):1005-9. Angiology. 1990. PMID: 2248422

8

Nicardipine in severe hypertension: oral therapy following intravenous treatment.

Wallin JD, Bienvenu GS, Cook E, Laddu A, Turlapaty P, Clifton GG. Wallin JD, et al. Among authors: clifton gg. Int J Clin Pharmacol Ther Toxicol. 1990 Jan;28(1):14-9. Int J Clin Pharmacol Ther Toxicol. 1990. PMID: 2303309

9

Pharmacokinetics, pharmacodynamics, and minimum effective clinical dose of intravenous nicardipine.

Cook E, Clifton GG, Vargas R, Bienvenu G, Williams R, Sambol N, McMahon G, Grandy S, Lai CM, Quon C, et al. Cook E, et al. Among authors: clifton gg. Clin Pharmacol Ther. 1990 Jun;47(6):706-18. doi: 10.1038/clpt.1990.97. Clin Pharmacol Ther. 1990. PMID: 2357865 Clinical Trial.

10

Intravenous nicardipine for the treatment of severe hypertension.

Wallin JD, Cook ME, Blanski L, Bienvenu GS, Clifton GG, Langford H, Turlapaty P, Laddu A. Wallin JD, et al. Among authors: clifton gg. Am J Med. 1988 Sep;85(3):331-8. doi: 10.1016/0002-9343(88)90582-7. Am J Med. 1988. PMID: 3414728

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters